Guideline on treatment intensification with injectable therapies beyond GLP-1 RA based therapies in type 2 diabetes

Diabetes Research and Clinical Practice · Published 2026-08-02 · DOI 10.1016/j.diabres.2026.113474

Free full text

Authors (22)

Yingying Luo, Jun Xia, Xiaomei Yao, Seyed Adel Jahed, Yong Mong Bee, Liming Chen, Siew Pheng Chan, Chaicharn Deerochanawong, Alice Pik Shan Kong, Khue Thy Nguyen, Xiaoying Li, Soo Lim, Navin Kumar Loganadan, Margaret McGill, Selva Elizabeth Trejo, Daisuke Yabe, Li Yan, Peipei Li, Zhan Zhao, Shihui Chen, Alice Y.Y. Cheng, Linong Ji

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Luo, Y., Xia, J., Yao, X., et al. (2026). Guideline on treatment intensification with injectable therapies beyond GLP-1 RA based therapies in type 2 diabetes. Diabetes Research and Clinical Practice. https://doi.org/10.1016/j.diabres.2026.113474

Related articles